GENOMAB Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
GENOMAB General Information
Description
Developer of humanized mouse models designed for preclinical research and drug discovery. The company's platform provides personalized humanized mice, custom model development, and mouse model licensing services, enabling academic institutions, contract research organizations, and pharmaceutical companies to conduct translational research and therapeutic development studies.
Contact Information
Website
www.genomab.comCorporate Office
- Care Of Harlem Biospace
- 423 West 127th Street
- New York, NY 10027
- United States
Corporate Office
- Care Of Harlem Biospace
- 423 West 127th Street
- New York, NY 10027
- United States
GENOMAB Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Generating Revenue |
GENOMAB Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Harlem Biospace | Accelerator/Incubator |
GENOMAB FAQs
-
When was GENOMAB founded?
GENOMAB was founded in 2019.
-
Where is GENOMAB headquartered?
GENOMAB is headquartered in New York, NY.
-
What industry is GENOMAB in?
GENOMAB’s primary industry is Biotechnology.
-
Is GENOMAB a private or public company?
GENOMAB is a Private company.
-
What is GENOMAB’s current revenue?
The current revenue for GENOMAB is .
-
Who are GENOMAB’s investors?
Harlem Biospace has invested in GENOMAB.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process